Therefore, we conducted CHX assay, MG132 assay and ubiquitination assay which suggests that CASC19 increases PSPC1 protein stability by reducing its ubiquitin-proteasome mediated degradation in pancreatic cancer. This evidence concerns the gene CASC19 and pancreatic neoplasm.